- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
Purpose Bitcoin ETF
Silver47 Exploration
Syntheia
CI Galaxy Bitcoin ETF
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Bee Vectoring Announces Highly Successful Blueberry Trial with New and Proprietary Honey Bee Dispenser System
Bee Victoring Technologies (TSXV:BEE) has announced successful trial results in blueberries. As quoted in the press release: The trial was conducted near Parrsborough, Nova Scotia, Canada in low bush blueberries with the Wild Blueberry Research Program at Dalhousie University using BVT’s newly developed honeybee system, consisting of a honey bee hive with proprietary dispenser technology …
Bee Victoring Technologies (TSXV:BEE) has announced successful trial results in blueberries.
As quoted in the press release:
The trial was conducted near Parrsborough, Nova Scotia, Canada in low bush blueberries with the Wild Blueberry Research Program at Dalhousie University using BVT’s newly developed honeybee system, consisting of a honey bee hive with proprietary dispenser technology through which BVT’s proprietary plant beneficial microbe BVT-CR7 is delivered to crops using honey bees. The trial was designed to determine the effectiveness of the BVT technology in controlling Botrytis blight (gray mold) and Monilinia blight (mummy berry), two common and devastating diseases affecting blueberry crops across North America, compared to untreated control and current chemicals standards used by growers, as well as increases in productivity of the crop measured by marketable yield.
“Our yields went up quite substantially when we used the BVT system, whether alone or in combination with chemical fungicides, but they didn’t go up where we used the fungicide alone,” said Dr. David Percival blueberry research program director and professor at Dalhousie University in Nova Scotia. “I was really surprised by the first results. I went back and double checked the raw yield data, then the spreadsheet to make sure the statistical program was correct. The results indicate the potential for floral blight disease control and increased berry yields with the use of BVT technology. Future work will allow us to fine tune the use recommendations.”
Ashish Malik, CEO of BVT added, “These are excellent results once again for the company and firmly establishes another major market opportunity. Notably, this was the first time we tested our honey bee delivery system in a replicated R&D study, and we got great results. Having a proven system that works with honey bees alongside our first system designed to work with commercial bumble bee hives allows us to reach a far wider market and gives us options to deliver solutions for growers based on the specific needs for their crops.”
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.